{"paper_id":"31d71126-22a9-402a-9707-ecbc467ab5e8","body_text":"False-positive diagnosis of uterine malignancy with raised 18F-fluorodeoxyglucose activity in adenomyosis: A case report\nAuthors/Creators\n- 1. Department of Obstetrics and Gynaecology, School of Women's and Children's Health, The University of New South Wales, Sydney, Australia.\n- 2. Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong, China.\nDescription\nPositron Emission Tomography - Computed Tomography (PET-CT) has been used to diagnose malignancy before surgery. However, there may be an increase in 18F-fluorodeoxyglucose (FDG) uptake in PET scans in benign conditions, leading to a false-positive diagnosis of malignancy and unnecessary surgery. This PET-CT investigation is expensive and is not without risk, including radiation and drug or contrast hypersensitivity. Although variable uterine uptakes of FDG activities in PET-CT had been reported in the literature, unawareness of its possibility in benign conditions could lead to a false alarm of malignancy. This paper reported a patient with a false-positive FDG finding presenting as a malignant uterine lesion for surgery, aiming to raise the clinical awareness of this finding.\nFiles\nWJARR-2022-0178.pdf\nFiles\n(960.9 kB)\n| Name | Size | Download all |\n|---|---|---|\n|\nmd5:53440d2936a7f9b6ad8c7992edad0a55\n|\n960.9 kB | Preview Download |","source_license":"CC0","license_restricted":false}